Assessment of Multimeric Structure and Ristocetin‐Induced Binding to Platelets of Von Willebrand Factor Present in Cryoprecipitate and Different Factor VIII Concentrates
- 5 March 1987
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 52 (1-2), 15-19
- https://doi.org/10.1111/j.1423-0410.1987.tb02981.x
Abstract
The multimeric structure of von Willebrand factor (vWF) and its ristocetin-induced binding to platelets, using a simple and very sensitive radiomonoclonal antibody-labeled vWF method, was compared in normal plasma, single-donor cryoprecipitate (CP) and five different antihemophilic factor (AHF) concentrates. All the AHF showed a lack of larger vWF multimers, an abnormal ''triplet'' pattern, and much lower vWF binding to platelets than that of plasma or CP, vWF being the lowest for those with a lesser proportion of larger vWF multimers. These results suggest that the combination of vWF multimeric analysis and the radiomonoclonal-labeled vWF method may be very useful in the assessment of AHF preparations.This publication has 11 references indexed in Scilit:
- MULTIMERIC ANALYSIS OF EIGHT LYOPHILIZED FACTOR VIII CONCENTRATESBritish Journal of Haematology, 1985
- Interaction of von Willebrand factor with human platelets in the plasma milieu.Journal of Clinical Investigation, 1984
- Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.Proceedings of the National Academy of Sciences, 1982
- Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to plateletsBlood, 1981
- Heightened Interaction between Platelets and Factor VIII/von Willebrand Factor in a New Subtype of von Willebrand's DiseaseNew England Journal of Medicine, 1980
- Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.Journal of Clinical Investigation, 1979
- Separation of human platelets from plasma proteins including factor VIIIVWF by a combined albumin gradient-gel filtration method using hepes bufferThrombosis Research, 1978
- Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activitiesPublished by American Medical Association (AMA) ,1976
- Failure of AHF concentrate to control bleeding in von Willebrand's diseaseThe American Journal of Medicine, 1976
- A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)Thrombosis and Haemostasis, 1975